william hauswirth

william hauswirth

University of Florida

H-index: 107

North America-United States

About william hauswirth

william hauswirth, With an exceptional h-index of 107 and a recent h-index of 54 (since 2020), a distinguished researcher at University of Florida, specializes in the field of retinal gene therapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

rAAV-compatible human mini promoters enhance transgene expression in rat retinal ganglion cells

Development of a translatable gene augmentation therapy for CNGB1-retinitis pigmentosa

A clinically viable approach to restoring visual function using optogenetic gene therapy

Maturation of synaptic ribbons and synaptogenesis occur after CaBP4 gene augmentation therapy

Methods for treating eye disease

Comparison of different gene-therapy methods to treat Leber hereditary optic neuropathy in a mouse model

Neuroprotective gene therapy by overexpression of the transcription factor MAX in rat models of glaucomatous neurodegeneration

Small angiotensin peptide expression system in mammalian cells

william hauswirth Information

University

Position

___

Citations(all)

41451

Citations(since 2020)

11248

Cited By

34867

hIndex(all)

107

hIndex(since 2020)

54

i10Index(all)

365

i10Index(since 2020)

257

Email

University Profile Page

Google Scholar

william hauswirth Skills & Research Interests

retinal gene therapy

Top articles of william hauswirth

rAAV-compatible human mini promoters enhance transgene expression in rat retinal ganglion cells

Experimental Eye Research

2024/2/1

Development of a translatable gene augmentation therapy for CNGB1-retinitis pigmentosa

Molecular Therapy

2023/7/5

A clinically viable approach to restoring visual function using optogenetic gene therapy

Molecular Therapy-Methods & Clinical Development

2023/6/8

Maturation of synaptic ribbons and synaptogenesis occur after CaBP4 gene augmentation therapy

Investigative Ophthalmology & Visual Science

2023/6/1

Methods for treating eye disease

2023/4/6

Comparison of different gene-therapy methods to treat Leber hereditary optic neuropathy in a mouse model

Frontiers in neuroscience

2023/3/27

Neuroprotective gene therapy by overexpression of the transcription factor MAX in rat models of glaucomatous neurodegeneration

Investigative Ophthalmology & Visual Science

2022/2/1

Small angiotensin peptide expression system in mammalian cells

2022/11/29

Methods and compositions for the expression of constitutively active rap1a from a vmd2 promoter

2022/11/3

Amelioration of Leigh syndrome induced by mouse blastocyst complementation with a mutant human mitochondrial ATP synthase 6

Clinical and Translational Discovery

2022/9

Reagents and methods for modulating cone photoreceptor activity

2022/6/16

Raav-guanylate cyclase compositions and methods for treating leber's congenital amaurosis-1 (lca1)

2022/6/16

Enhanced human opsin promoter for rod specific expression

2022/6/9

Long-term follow up of gene therapy for NPHP5-LCA in a canine model shows restoration of photoreceptor function and vision for> 5 years

Investigative Ophthalmology & Visual Science

2022/6/1

Gene augmentation therapy restores vision in a CaBP4-mutant canine model of cone-rod synaptic disorder

Investigative Ophthalmology & Visual Science

2022/6/1

Gene therapy restores mitochondrial function and protects retinal ganglion cells in optic neuropathy induced by a mito-targeted mutant ND1 gene

Gene therapy

2022/6

Dual-AAV vector-based systems and methods for delivering oversized genes to mammalian cells

2022/5/10

XIAP gene therapy effects on retinal ganglion cell structure and function in a mouse model of glaucoma

Gene therapy

2022/4

Adeno-associated viral vectors for the treatment of best disease

2022/2/3

A codon optimized otoferlin aav dual vector gene therapy

2021/12/23

See List of Professors in william hauswirth University(University of Florida)

Co-Authors

academic-engine